AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ESOMEPRAZOLE 20 Mg ;
21 registrations across 1 African market— 21 active
Markets with ESOMEPRAZOLE 20 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Esovaxole 20 mg Hard Gelatin Capsules Containing Delayed Release Pellets | 🇪🇬Egypt | Bio Med For Pharmaceutical Industries (BIOMED) | active | — |
| Razopump 20 mg delayed release hard gelatin capsule | 🇪🇬Egypt | pharma cure pharmaceutical industries | active | — |
| Nexicure 20 mg Enteric coated granules for delayed release oral suspension | 🇪🇬Egypt | Zeta Pharma for Pharmaceutical Industries (Zeta Pharma) | active | — |
| Esomeprazole-Eva Pharma 20 mg Delayed Release Granules for Oral Suspension | 🇪🇬Egypt | Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharma | active | — |
| Esmoproton 20 mg Delayed release hard gelatin capsule containing pellets | 🇪🇬Egypt | Wadi El Neel Benta for Pharmaceuticals and Medical Devices | active | — |
| Razopump 20 mg delayed release hard gelatin capsule | 🇪🇬Egypt | pharma cure pharmaceutical industries | active | — |
| Esomeprazole-Eva Pharma 20 mg Delayed Release Granules for Oral Suspension | 🇪🇬Egypt | Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharma | active | — |
| Esmoproton 20 mg Delayed release hard gelatin capsule containing pellets | 🇪🇬Egypt | Wadi El Neel Benta for Pharmaceuticals and Medical Devices | active | — |
| Ezoprazole ®20 mg Delayed Release capsule containing pellets | 🇪🇬Egypt | Amoun Pharmaceutical Company | active | — |
| Esomeprazole-October Pharma Delayed Release Capsule | 🇪🇬Egypt | October Pharma | active | — |
| Meprazole® 20 mg Delayed release hard gelatin capsules containing enteric coated pellets | 🇪🇬Egypt | Egyptian International Pharmaceutical Industries Company (EIPICO) | active | — |
| Esomeprazole-October Pharma Delayed Release Capsule | 🇪🇬Egypt | October Pharma | active | — |
| Neximash 20 mg delayed release hard gelatin capsule | 🇪🇬Egypt | Mash for pharmaceutical Industries and cosmetic - mash premiere | active | — |
| Esopiroxan 20mg Delayed release enteric coated pellets in hard gelatin capsule | 🇪🇬Egypt | al andalous for pharmaceutical industries | active | — |
| Esmatac 20 mg delayed release hard gelatin capsule | 🇪🇬Egypt | Egyptian Group for Pharmaceutical Industries - EGPI | active | — |
| Retaczol Delayed release powder for oral suspension in sachet | 🇪🇬Egypt | Rector Pharma | active | — |
| Nexicure 20 mg Enteric coated granules for delayed release oral suspension | 🇪🇬Egypt | Zeta Pharma for Pharmaceutical Industries (Zeta Pharma) | active | — |
| Esovaxole 20 mg Hard Gelatin Capsules Containing Delayed Release Pellets | 🇪🇬Egypt | Bio Med For Pharmaceutical Industries (BIOMED) | active | — |
| Esmatac 20 mg delayed release hard gelatin capsule | 🇪🇬Egypt | Egyptian Group for Pharmaceutical Industries - EGPI | active | — |
| Esopiroxan 20mg Delayed release enteric coated pellets in hard gelatin capsule | 🇪🇬Egypt | al andalous for pharmaceutical industries | active | — |
| Neximash 20 mg delayed release hard gelatin capsule | 🇪🇬Egypt | Mash for pharmaceutical Industries and cosmetic - mash premiere | active | — |
ESOMEPRAZOLE 20 Mg ; in Africa — Regulatory Overview
ESOMEPRAZOLE 20 Mg ; is registered across 1 African markets with 21 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 21 registrations, 21 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.